New human data hints at psychedelics' potential to combat inflammation

Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses.

Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease. (Image credit: Cannabis-Pic)